Precursor lesions of oesophageal cancer in a low-risk population in China: Comparison with high-risk populations

1984 ◽  
Vol 34 (5) ◽  
pp. 599-602 ◽  
Author(s):  
M. Crespi ◽  
N. Muńoz ◽  
A. Grassi ◽  
Shen Qiong ◽  
Wang Kuo Jing ◽  
...  
Keyword(s):  
High Risk ◽  
Oesophageal Cancer ◽  
Low Risk ◽  
Precursor Lesions ◽  
Risk Population ◽  
High Risk Populations

PRECURSOR LESIONS OF OESOPHAGEAL CANCER IN YOUNG PEOPLE IN A HIGH-RISK POPULATION IN CHINA

The Lancet ◽  
1989 ◽  
Vol 334 (8674) ◽  
pp. 1239-1241 ◽  
Author(s):  
Jürgen Wahrendorf ◽  
QiuSong Liang ◽  
Nubia Muñoz ◽  
Richard Raedsch ◽  
Jenny Chang-Claude ◽  
...  
Keyword(s):  
High Risk ◽  
Young People ◽  
Oesophageal Cancer ◽  
High Risk Population ◽  
Precursor Lesions ◽  
Risk Population

PRECURSOR LESIONS OF OESOPHAGEAL CANCER IN HIGH-RISK POPULATIONS IN IRAN AND CHINA

The Lancet ◽  
1982 ◽  
Vol 319 (8277) ◽  
pp. 876-879 ◽  
Author(s):  
N. Muñoz ◽  
A. Grassi ◽  
Shen Qiong ◽  
M. Crespi ◽  
Wang Guo Qing ◽  
...  
Keyword(s):  
High Risk ◽  
Oesophageal Cancer ◽  
Precursor Lesions ◽  
High Risk Populations

Preventive effect of trimetazidine on contrast-induced nephropathy undergoing percutaneous coronary intervention in elderly moderate and high risk diabetics stratified by mehran score

Perfusion ◽  
2020 ◽  
pp. 026765912095205
Author(s):  
Xue Zhang ◽  
Peng Zhang ◽  
Shicheng Yang ◽  
Wenyuan Li ◽  
Xiuzhen Men ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
High Risk ◽  
Serum Creatinine ◽  
Coronary Intervention ◽  
Low Risk ◽  
Control Group ◽  
Preventive Effect ◽  
Contrast Induced Nephropathy ◽  
Risk Population ◽  
Percutaneous Coronary

Background: The aim of this research was to use the Mehran risk score to classify elderly diabetics with coronary heart disease to assess the preventive effect of trimetazidine on contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in different risk population. Methods: An uncompromised of 760 elderly diabetics that went through PCI were included in this research. The patients were first divided into three groups in the light of MRS: low-risk, moderate-risk, and high-risk group, then randomized into trimetazidine group and the control group respectively. The first endpoint was the amount of CIN, which is described as a rise in serum creatinine levels by ⩾44.2 μmol/L or ⩾25% ratio within 48 or 72 hours after medication. Second endpoint included differences in creatinine clearance rate (CrCl), blood urea nitrogen (BUN), serum creatinine (Scr), cystatin-C (Cys-C), and the incidence of major adverse events after administration. Results: In the three groups, the incidence of CIN in trimetazidine and control group was 5.0% versus 4.9%(χ2 = 0.005, p > 0.05), 8.0% versus 18.0% (χ2 = 7.685, p < 0.05), 10.4% versus 27.1% (χ2 = 4.376, p < 0.05), respectively. The multivariable logistic regression result demonstrated that trimetazidine intervention was a profitable element of CIN in moderate and high-risk groups (OR = 0.294, 95% CI 0.094-0.920, p = 0.035). Conclusion: Our study confirmed that trimetazidine can be considered for preventive treatment of CIN occurrence in elderly diabetics with moderate and high-risk population, while there is no obvious advantage compared with hydration therapy in low-risk patients.

The Prevalence of the Human Papillomavirus in Cervix and Vagina in Low-risk and High-risk Populations

2004 ◽  
Vol 36 (6-7) ◽  
pp. 456-459 ◽  
Author(s):  
Marc Baay ◽  
Veronique Verhoeven ◽  
Kristien Wouters ◽  
Filip Lardon ◽  
Pierre Van Damme ◽  
...  
Keyword(s):  
Human Papillomavirus ◽  
High Risk ◽  
Low Risk ◽  
High Risk Populations

scholarly journals THE PREDICTING FACTORS FOR CHRONIC KIDNEY DISEASE AMONG HIGH-RISK POPULATION IN LOWER NORTHERN, THAILAND

2020 ◽  
Vol 20 (2) ◽  
pp. 268-275
Author(s):  
Primprapha Konkaew ◽  
Pattama Suphunnakul
Keyword(s):  
Risk Factors ◽  
Chronic Kidney Disease ◽  
Health Literacy ◽  
High Risk ◽  
Kidney Disease ◽  
Sampling Technique ◽  
High Risk Population ◽  
Cross Sectional ◽  
Risk Population ◽  
High Risk Populations

This research aimed to explore the factors predicting chronic kidney disease (CKD) in the high-risk population. A cross-sectional study had been conducted in the high-risk populations investigated with and without CKD were the participants. A total of 1,463 samples was enrolled by a multistage sampling technique was used to recruit participants from five provinces in the lower northern of Thailand. Data were collected using a questionnaire and analyzed with descriptive statistics, and binary logistic regression. The results were revealed the risk factors affecting CKD including aged, dyslipidemia, being ill of diabetes mellitus, being unable to control blood pressure, being unable to control blood sugar level, taking add more salty seasoning to the cooked food, cooking with sodium salt over the prescribed amount, using the non-steroidal anti-inflammatory drug, lack of exercise, herbal plants consumption as drugs that are toxic to the kidney, edema, foamy urine, and nocturia. All risk factors were able to co-predict the risk to CKD about 83.2% at the 0.05 level of significance. Therefore, to prevent early states with CKD in the high-risk populations, the focus should be on encouraging health literacy because health literary it has a positive relationship with health-promoting behaviors. The health care provider needs to concentrate on increasing health literacy for self– management with them.

scholarly journals Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg

2020 ◽  
Vol 9 (12) ◽  
pp. 4066
Author(s):  
Nicola Capasso ◽  
Raffaele Palladino ◽  
Emma Montella ◽  
Francesca Pennino ◽  
Roberta Lanzillo ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
High Risk ◽  
Cross Sectional Study ◽  
Low Risk ◽  
High Risk Population ◽  
Chi Square ◽  
Cross Sectional ◽  
Risk Population ◽  
Exact Test ◽  
Chi Square Test

Background. We compared the prevalence of SARS-CoV-2 IgG/IgM in multiple sclerosis (MS), low-risk, and high-risk populations and explored possible clinical correlates. Methods. In this cross-sectional study, we recruited MS patients, low-risk (university staff from non-clinical departments), and high-risk individuals (healthcare staff from COVID-19 wards) from 11 May to 15 June 2020. We used lateral flow immunoassay to detect SARS-CoV-2 IgG and IgM. We used t-test, Fisher’s exact test, chi square test, or McNemar’s test, as appropriate, to evaluate between-group differences. Results. We recruited 310 MS patients (42.3 ± 12.4 years; females 67.1%), 862 low-risk individuals (42.9 ± 13.3 years; females 47.8%), and 235 high-risk individuals (39.4 ± 10.9 years; females 54.5%). The prevalence of SARS-CoV-2 IgG/IgM in MS patients (n = 9, 2.9%) was significantly lower than in the high-risk population (n = 25, 10.6%) (p < 0.001), and similar to the low-risk population (n = 11, 1.3%) (p = 0.057); these results were also confirmed after random matching by age and sex (1:1:1). No significant differences were found in demographic, clinical, treatment, and laboratory features. Among MS patients positive to SARS-CoV-2 IgG/IgM (n = 9), only two patients retrospectively reported mild and short-lasting COVID-19 symptoms. Conclusions. MS patients have similar risk of SARS-CoV-2 infection to the general population, and can be asymptomatic from COVID-19, also if using treatments with systemic immunosuppression.

Sign in / Sign up

Export Citation Format

Share Document